Clinical Breakout Session 3
Tracks
Icon Room 2
Tuesday, August 29, 2023 |
3:30 PM - 5:00 PM |
Icon 2 |
Overview
Icon 2
Chair: Dr Helen Moore
Clinical Session Speakers: Dr Paula Keating, Dr Rebecca Wayte, Dr Anna Brooks
Chair: Dr Helen Moore
Clinical Session Speakers: Dr Paula Keating, Dr Rebecca Wayte, Dr Anna Brooks
Speaker
Ms Paula Keating
Scientific Office
Canterbury Health Laboratories, Te Whatu Ora Health New Zealand Waitaha
Specialist Flow Cytometry tests for diagnosis of primary immunodeficiencies
3:30 PM - 4:00 PMBiography
Dr Keating is registered with the Medical Laboratory Science Council (MLS) and has 30 years experience in immunology. She develops diagnostic tests for the NZ clinical immunology service. She provides specialist functional assays using flow cytometry to aid diagnosis of immunodeficiencies.
Dr Rebecca Wayte
BMT / Car T Fellow
Royal Prince Alfred Hospital
Increased CAR T-cell expansion assessed by immunophenotyping early post infusion reveals improved clinical response in large B cell lymphoma
4:00 PM - 4:30 PMBiography
Dr Rebecca Wayte is the current CAR T-cell therapy/bone marrow transplant fellow at Royal Prince Alfred Hospital. She attained fellowship this year after training at Royal Prince Alfred, Concord and Westmead Hospitals and has a particular interest in transplantation and cellular therapy.
Dr Anna Brooks
Senior Lecturer
University of Auckland
Spectral cytometry in the clinical arena
4:30 PM - 5:00 PMBiography
Dr Anna Brooks is a Senior Lecturer teaching postgraduate virology, biotechnology, and advanced cell characterization technologies at the University of Auckland. In addition, she is Director of Auckland Cytometry, the flow cytometry Shared Resource Laboratory for the Faculty of Science. Dr Brooks has over 20 years’ experience in human immunology, with specific training and expertise in advanced cell characterisation using high dimensional spectral flow cytometry. Dr Brooks’ research focuses on immunoprofiling of various immune perturbations and is currently leading a study to understand the underlying immune dysfunction of Long Covid and its relationship with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). In addition, she is involved in consulting or collaborations on a number of academic, clinical and commercial projects, including clinical trials involving flow cytometry services.
Chair
Helen Moore
Haematologist
Waikato DHB